Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$43.21 - $57.6 $185,500 - $247,276
-4,293 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$52.8 - $60.32 $51,744 - $59,113
-980 Reduced 18.59%
4,293 $238,000
Q2 2021

Aug 16, 2021

SELL
$51.29 - $59.15 $10,565 - $12,184
-206 Reduced 3.76%
5,273 $286,000
Q1 2021

May 17, 2021

SELL
$42.18 - $56.07 $77,020 - $102,383
-1,826 Reduced 25.0%
5,479 $307,000
Q4 2020

Feb 16, 2021

SELL
$35.18 - $43.52 $11,961 - $14,796
-340 Reduced 4.45%
7,305 $318,000
Q3 2020

Nov 16, 2020

BUY
$37.98 - $48.72 $101,102 - $129,692
2,662 Added 53.42%
7,645 $298,000
Q2 2020

Aug 14, 2020

BUY
$31.07 - $44.74 $154,821 - $222,939
4,983 New
4,983 $215,000
Q1 2020

May 15, 2020

SELL
$22.46 - $42.24 $122,474 - $230,334
-5,453 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$39.01 - $47.51 $212,721 - $259,072
5,453 New
5,453 $226,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $538M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Zebra Capital Management LLC Portfolio

Follow Zebra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.